Vimarsana
Biggest News Aggregation in the World

Page 19 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Vox Royalty : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Vox Royalty : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS Date Thursday, June 8, 2023 ... | May 9, 2023

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN DIEGO, May 5, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® , a clinical-stage targeted oncology company, today announced that the company granted equity awards to 2 new employees... | June 17, 2023

uniQure Inc.: uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

uniQure Inc.: uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass. and AMSTERDAM, May 02, 2023(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the Company granted

uniQure Announces Inducement Grants Under Nasdaq Listing - Vimarsana News

uniQure Announces Inducement Grants Under Nasdaq Listing

LEXINGTON, Mass. and AMSTERDAM, May 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative...

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SEATTLE, May 2, 2023 /PRNewswire/ -- CTI BioPharma Corp. , a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related... | May 2, 2023